John Roderick ten Bosch
CIK 2087126 · SVP of Laboratory Operations · last filed 2026-07-01
John Roderick ten Bosch is a SVP of Laboratory Operations who has filed 5 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing shows the insider sold $169.9K of BLLN on Jul 1, 2026. Across all open-market trades the lifetime net is −$457.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.28M
1
5
-$457.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLLN | SVP of Laboratory Operations | 33,552 | $127.43 | $4.28M | -$457.3K | 2 | 2026-07-01 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-01 | BLLN | Sell (S) | −1,416 | -$169.9K | EDGAR |
| 2026-06-29 | BLLN | Notice (144) | −1,416 | -$169.9K | EDGAR |
| 2026-06-17 | BLLN | Sell (S) | −2,832 | -$287.4K | EDGAR |
| 2026-06-15 | BLLN | Notice (144) | −2,832 | -$287.4K | EDGAR |
| 2025-11-12 | — | Mixed | +800 | $48.0K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.